UCSF

Tagged: conflict of interest (COI)

Analysis finds sponsorship biases in animal studies may differ from those in clinical trials

A new analysis of dozens of animal studies evaluating the effects of the cholesterol-lowering statin class of drugs on atherosclerosis found larger positive effects in studies not sponsored by the pharmaceutical industry as compared to those that were industry sponsored.

Study finds Medicaid drug selection COI policies vary, may be inadequate

How well do states’ policies address possible conflicts of interest of committee members who decide which drugs get Medicaid reimbursement? The question looms especially large as impending federal health care reform increases the number of patients covered by the state-run drug formularies.

Conflicts of interest significantly underreported in systematic reviews of drug efficacy, safety

Systematic reviews seek to answer key questions about the relative effectiveness and safety of medical interventions by selecting, combining, and critically evaluating the research in published medical literature.

New NIH funding awarded to the Department of Clinical Pharmacy in 2011

New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included these on-going projects by faculty in the Department of Clinical Pharmacy:

Bero serves on IOM committee that reports on conflict of interest

UCSF School of Pharmacy researcher Lisa Bero, PhD, served with UCSF School of Medicine colleagues Bernard Lo, MD, and Deborah Grady,

Bero and team reveal incomplete reporting of clinical drug trial data

Research by UCSF School of Pharmacy faculty member Lisa Bero, PhD, and UCSF colleagues Kristen Rising, MD, and Peter Bacchetti,

Research bias shown to be complicated

Research studies can be designed to influence the results, comments Lisa Bero, PhD, UCSF School of Pharmacy faculty member and expert on industry sponsorship of research and conflict of interest.